Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review

A. Clegg, J. Bryant, T. Nicholson, L. McIntyre, S. de Broe, K. Gerard, Norman Robert Waugh

Research output: Contribution to journalArticle

112 Citations (Scopus)
Original languageEnglish
JournalHealth Technology Assessment
Volume5
Issue number1
Publication statusPublished - 2001

Cite this

Clegg, A., Bryant, J., Nicholson, T., McIntyre, L., de Broe, S., Gerard, K., & Waugh, N. R. (2001). Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Health Technology Assessment, 5(1).